Three GLP-1 treatments are currently licensed for weight management in the UK: Mounjaro (tirzepatide), Wegovy (semaglutide), Saxenda and Nevolat (liraglutide)
Safety Considerations, Provider Oversight, and Eligibility Criteria Legal compounding requires robust safety protocols: source chemical verification, sterility testing for injectable forms, strength and purity checks, and expiration dating
Not everyone tolerates injections well
Our GLP-1 gummies are a convenient alternative, allowing you to simply pop one in your mouth whenever it's time for your dose
All treatments are prescribed by a licensed Family Nurse Practitioner (FNP-C) after a comprehensive consultation
Many patients experience nausea, early satiety, bloating, or changes in bowel habits as their digestive system adapts to the medicine